Upgrade to SI Premium - Free Trial

Clinuvel Pharmaceuticals Ltd Sponsored Adr (CLVLY)

7.35 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

A decade of profitability provides foundation for CLINUVEL’s U.S. expansion August 27, 2026 1:42 AM - Globe NewsWire CLINUVEL implements strategic reorganisation to refocus on U.S. markets July 23, 2026 12:10 AM - Globe NewsWire CLINUVEL’s ADS to commence trading on Nasdaq July 20, 2026 1:37 AM - Globe NewsWire SCENESSE® approved for EPP in Canada July 13, 2026 1:10 AM - Globe NewsWire Full Article List